Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Singh BN. Searching for the Ideal Class III Antiarrhythmic Agent: How Pure Should they Be? J Cardiovasc Pharmacol Ther 1997;2:239-242. [PMID: 10684464 DOI: 10.1177/107424849700200401] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]

For:	Singh BN. Searching for the Ideal Class III Antiarrhythmic Agent: How Pure Should they Be? J Cardiovasc Pharmacol Ther 1997;2:239-242. [PMID: 10684464 DOI: 10.1177/107424849700200401] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]

Number

Cited by Other Article(s)

Wadhani N, Singh BN. Prolongation of repolarization as antifibrillatory action revisited: drug combination therapy in atrial fibrillation. J Cardiovasc Pharmacol Ther 2005;10:149-52. [PMID: 16211202 DOI: 10.1177/107424840501000301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]

Singh BN, Lopez B. Atrial Fibrillation: Defining Some Unanswered Questions. J Cardiovasc Pharmacol Ther 1998;3:195-200. [PMID: 10684497 DOI: 10.1177/107424849800300212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]